IBDEI0UK ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15075,0)
 ;;=196.3^^89^902^99
 ;;^UTILITY(U,$J,358.3,15075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15075,1,4,0)
 ;;=4^196.3
 ;;^UTILITY(U,$J,358.3,15075,1,5,0)
 ;;=5^Mets to Lymph Nodes,Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,15075,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,15076,0)
 ;;=196.0^^89^902^100
 ;;^UTILITY(U,$J,358.3,15076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15076,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,15076,1,5,0)
 ;;=5^Mets to Lymph Nodes,Cervical
 ;;^UTILITY(U,$J,358.3,15076,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,15077,0)
 ;;=196.1^^89^902^101
 ;;^UTILITY(U,$J,358.3,15077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15077,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,15077,1,5,0)
 ;;=5^Mets to Lymph Nodes,Mediastinal 
 ;;^UTILITY(U,$J,358.3,15077,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,15078,0)
 ;;=196.8^^89^902^102
 ;;^UTILITY(U,$J,358.3,15078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15078,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,15078,1,5,0)
 ;;=5^Mets to Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,15078,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,15079,0)
 ;;=V10.51^^89^902^56
 ;;^UTILITY(U,$J,358.3,15079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15079,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,15079,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,15079,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,15080,0)
 ;;=V10.3^^89^902^57
 ;;^UTILITY(U,$J,358.3,15080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15080,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,15080,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,15080,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,15081,0)
 ;;=V10.41^^89^902^58
 ;;^UTILITY(U,$J,358.3,15081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15081,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,15081,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,15081,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,15082,0)
 ;;=V10.05^^89^902^59
 ;;^UTILITY(U,$J,358.3,15082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15082,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,15082,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,15082,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,15083,0)
 ;;=V10.03^^89^902^60
 ;;^UTILITY(U,$J,358.3,15083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15083,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,15083,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,15083,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,15084,0)
 ;;=V10.60^^89^902^62
 ;;^UTILITY(U,$J,358.3,15084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15084,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,15084,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,15084,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,15085,0)
 ;;=V10.11^^89^902^63
 ;;^UTILITY(U,$J,358.3,15085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15085,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,15085,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,15085,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,15086,0)
 ;;=V10.79^^89^902^64
 ;;^UTILITY(U,$J,358.3,15086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15086,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,15086,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,15086,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,15087,0)
 ;;=V10.82^^89^902^65
 ;;^UTILITY(U,$J,358.3,15087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15087,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,15087,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,15087,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,15088,0)
 ;;=V10.02^^89^902^68
 ;;^UTILITY(U,$J,358.3,15088,1,0)
 ;;=^358.31IA^5^2
